BROADWOOD CAPITAL INC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001278387
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 12 positions · Total reported value $1.70B · Top-10 concentration 99.8% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 0.0% · 0 new · 0 cut · 0 exited
Active Share (vs S&P 500): 99.8% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking
In its Q4 2025 13F filing, BROADWOOD CAPITAL INC disclosed 12 equity positions with a combined reported value of $1.70B. The filing implies a focused portfolio: its ten largest positions account for 99.8% of reported value. HoldingsHub classifies the profile as Mid / Focused / Consumer Tilt / Buy & Hold.
The largest disclosed positions as of Q4 2025 were MNST ($628.62M), AXON ($393.86M), STAA ($346.80M). By sector, the heaviest allocations are Consumer Staples 36.9%, Health Care 30.3%. Versus the prior quarter, allocation shifted toward Consumer Staples (+3.5pp), Consumer Discretionary (+2.4pp) and away from Industrials (-6.8pp).
Versus the prior quarter, BROADWOOD CAPITAL INC opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 85% of names.
The largest new positions opened in Q4 2025 were GIL ($7.04M).
Of the 1 positions fully exited versus the prior quarter, the largest were HBI ($1.83M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
- GIL GILDAN ACTIVEWEAR INC · $7.04M
Fully Exited (vs previous quarter)
- HBI HANESBRANDS INC · prev qtr: $1.83M
Insider Transactions (Form 4)
Latest BROADWOOD CAPITAL INC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-04-27 | Buy | Insight Molecular Diagnostics Inc. | — | — | SEC filing |
| 2026-04-27 | Buy | Insight Molecular Diagnostics Inc. | 250,923 | $3.64 | SEC filing |
| 2026-04-24 | Buy | Insight Molecular Diagnostics Inc. | — | — | SEC filing |
| 2026-04-24 | Buy | Insight Molecular Diagnostics Inc. | 38,880 | $3.53 | SEC filing |
| 2026-04-23 | Buy | Insight Molecular Diagnostics Inc. | — | — | SEC filing |
| 2026-04-23 | Buy | Insight Molecular Diagnostics Inc. | 280,381 | $3.50 | SEC filing |
| 2026-04-20 | Buy | Insight Molecular Diagnostics Inc. | — | — | SEC filing |
| 2026-04-20 | Buy | Insight Molecular Diagnostics Inc. | 40,690 | $3.88 | SEC filing |
Fund Profile
Broadwood Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 6 US equity positions with a combined value of $1.91B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-73853 (status: Approved), registered 2012-03-27
- Regulatory AUM (Form ADV): $1.71B as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
- Website: broadwoodcapital.com
Portfolio Structure
- 6 positions · $1.91B reported value (Q2 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: MNST (MONSTER BEVERAGE CORP NEW) at 40.7%
- Average position size: $318.86M
Sector Tilt
- Consumer Staples 40.7%
- Health Care 31.5%
- Industrials 20.3%
- (classified holdings cover 93% of value)
Quarterly Activity
- Q2 2026: 1 added
- 5 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
8.20M | $628.62M | 36.93% | Reduce | |
| 2 |
|
693.50K | $393.86M | 23.14% | Hold | |
| 3 |
|
15.02M | $346.80M | 20.37% | Add | |
| 4 |
|
474.92K | $116.91M | 6.87% | Hold | |
| 5 |
|
11.41M | $85.58M | 5.03% | Hold | |
| 6 |
|
49.56M | $82.77M | 4.86% | Hold | |
| 7 |
|
150.00K | $16.77M | 0.98% | Hold | |
| 8 |
|
820.00K | $12.57M | 0.74% | Hold | |
| 9 |
|
183.00K | $7.56M | 0.44% | Hold | |
| 10 |
|
112.75K | $7.04M | 0.41% | New | |
| 11 |
|
52.50K | $3.64M | 0.21% | Hold | |
| 12 |
|
54.48K | $104.23K | 0.01% | Reduce | |
FAQ
What did BROADWOOD CAPITAL INC buy in 2025-Q4?
In its 2025-Q4 13F filing, BROADWOOD CAPITAL INC reported 12 equity positions worth $1.70B in aggregate; its largest disclosed positions were MNST ($628.62M), AXON ($393.86M), STAA ($346.80M).
How large is BROADWOOD CAPITAL INC's portfolio?
BROADWOOD CAPITAL INC reported $1.70B of long equity holdings across 12 positions as of 2025-Q4. Top-10 holdings account for 99.8% of reported value.
What is BROADWOOD CAPITAL INC's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Consumer Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.